Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial.
about
Early interventions to prevent psychosis: systematic review and meta-analysisA systematic review of mental health outcome measures for young people aged 12 to 25 yearsEffects of methamphetamine administration on information gathering during probabilistic reasoning in healthy humansResting EEG in psychosis and at-risk populations--a possible endophenotype?Endophenotypes in Schizophrenia for the Perinatal Period: Criteria for Validation.Cortical and Striatal Reward Processing in Parkinson's Disease Psychosis.Early specific cognitive-behavioural psychotherapy in subjects at high risk for bipolar disorders: study protocol for a randomised controlled trial.A critique of the "ultra-high risk" and "transition" paradigm.Prevention and treatment of long-term social disability amongst young people with emerging severe mental illness with social recovery therapy (The PRODIGY Trial): study protocol for a randomised controlled trialFamily-focused treatment for adolescents and young adults at high risk for psychosis: results of a randomized trialAttenuated psychosis and the schizophrenia prodrome: current status of risk identification and psychosis preventionWhither the attenuated psychosis syndrome?DSM-5: a collection of psychiatrist views on the changes, controversies, and future directions.The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol for a randomised controlled trialNew Targets for Prevention of Schizophrenia: Is It Time for Interventions in the Premorbid Phase?Clinical effectiveness and cost-effectiveness of tailored intensive liaison between primary and secondary care to identify individuals at risk of a first psychotic illness (the LEGs study): a cluster-randomised controlled trial.Cognitive behavioral therapy for subjects at ultrahigh risk for developing psychosis: a randomized controlled clinical trial.Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians.Psychiatric morbidity, functioning and quality of life in young people at clinical high risk for psychosis.Mismatch negativity as a "translatable" brain marker toward early intervention for psychosis: a review.Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis.Risk of mental illness in offspring of parents with schizophrenia, bipolar disorder, and major depressive disorder: a meta-analysis of family high-risk studies.A case report of cognitive behavioural therapy for social anxiety in an ultra-high risk patient.Research strategies and priorities to improve the lives of people with schizophrenia: executive summary of the Ernst Strüngmann Forum on schizophrenia.Cognitive interventions targeting brain plasticity in the prodromal and early phases of schizophrenia.Attenuated psychosis syndrome in DSM-5.Neurocognitive functioning in schizophrenia and during the early phases of psychosis: targeting cognitive remediation interventions.Biofeedback to treat anxiety in young people at clinical high risk for developing psychosis.Neuroinflammation and Oxidative Stress in Psychosis and Psychosis RiskStress Sensitivity and Psychotic Experiences in 39 Low- and Middle-Income Countries.Improving outcomes of first-episode psychosis: an overview.Drugs for kids: good or bad?Improvement in Negative Symptoms and Functioning in Cognitive-Behavioral Social Skills Training for Schizophrenia: Mediation by Defeatist Performance Attitudes and Asocial Beliefs.Metacognitive beliefs as psychological predictors of social functioning: An investigation with young people at risk of psychosis.Relating to the Speaker behind the Voice: What Is Changing?Levels of serum brain-derived neurotropic factor in individuals at ultra-high risk for psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS).NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders-medium-term follow-up and clinical course.Lack of evidence to favor specific preventive interventions in psychosis: a network meta-analysis.Efficacy and Acceptability of Interventions for Attenuated Positive Psychotic Symptoms in Individuals at Clinical High Risk of Psychosis: A Network Meta-Analysis.Identifying and treating the prodromal phases of bipolar disorder and schizophrenia
P2860
Q22242061-7365EE85-89FB-4DDB-8E49-E5609B3E2B00Q28082928-2E4D4FA9-1C03-4E39-8DFF-127634AC4E9AQ28541201-7FFBFA2E-4BCA-40DE-9E0E-CDD08FCDC178Q28660572-8C909E66-8E81-42C7-A1D7-65F72A4C238CQ30380523-90C47695-0E61-4581-8740-79F78AFE3D8DQ33593735-AD8203D2-B752-4A87-9116-AA8B5A4B65BBQ33608322-0B95E225-037F-472F-81F8-6973BD05177FQ33670654-4AC172B7-4049-46D7-9282-0A6622B05C9AQ33892036-D6199A04-C067-4661-B957-209218ED78ACQ33954717-80BF04FD-0F50-48F0-9170-BA44B97254B6Q34644978-51EE2AA3-E2DA-4370-B635-5661D9E28FF9Q34645261-747275E2-C96C-44E0-88B2-A92D643B2A02Q35042639-4BB328EB-EBD9-48C7-A4E8-BC602FF07511Q35052697-863945B8-116A-4928-8CE1-3461F9C0765FQ35739029-98A0B146-DC06-49BB-90A2-718F94E4AB06Q36269831-56001CF5-F448-4DAB-8EC6-AB78B46BC1A9Q36386323-0EE63F6F-8F20-48DB-9711-4CF744BC6B19Q36910682-D8CC9594-8830-40F0-B2FE-B2B5C25B203DQ37098386-9132D087-D007-465F-BF4B-0C8E56A93B3AQ37189916-7C3AD60F-3FCD-4118-A7F6-8B6EF52CE449Q37451389-C5270E13-F44E-4347-B5ED-0218F636FF56Q37451503-657EB6B4-6693-4A64-800C-5039ECD9F548Q37458968-25651CEC-287D-4A63-B4B0-6C0005FB1855Q37598281-9E46A2FB-A461-45BE-A180-37D3B8183CBBQ38072452-E1447C01-CAE6-4F7C-A11E-2404460A69CFQ38114968-3FACDA10-A7E3-49AC-8D16-9F1DE2BF3EC3Q38148760-7B5694AD-5F99-490E-931E-69134677F8D9Q38826685-9A9D11B9-0D19-4DF3-9CA6-178CAC65050BQ38901529-53E8CEDB-6947-4D3A-8D12-AA4DD2D845B6Q39826129-399559AA-6D94-48F4-AA83-813BB518086FQ41658737-FD80727B-31F4-43E4-907A-D7AFEAC95883Q42326520-201F6762-DAEC-4D9C-8373-228488B99FD3Q46364412-E81298D0-D9C5-4273-BF74-FBBF495D6A7CQ47614867-4E58824B-FFF1-4CC8-ADD4-487161A9DDFDQ49214560-068B5596-D8BA-468A-AF94-A03379EF73E5Q53424592-CA79FE88-F5C8-4B78-99F9-9CDF666A13C8Q55330019-B912A860-C82A-464B-9A4D-32DF27A7483FQ55361260-BF225D66-1E9A-4EB7-A3CB-F9C351587C1AQ55397391-A1D059CB-C316-4F8A-900A-3110B4B33834Q58575795-D25D657C-CA33-4187-BD0E-84DB8D714B85
P2860
Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Early detection and interventi ...... e randomised controlled trial.
@ast
Early detection and interventi ...... e randomised controlled trial.
@en
type
label
Early detection and interventi ...... e randomised controlled trial.
@ast
Early detection and interventi ...... e randomised controlled trial.
@en
prefLabel
Early detection and interventi ...... e randomised controlled trial.
@ast
Early detection and interventi ...... e randomised controlled trial.
@en
P2093
P2860
P50
P1433
P1476
Early detection and interventi ...... te randomised controlled trial
@en
P2093
Andrew I Gumley
Anthony P Morrison
Graham Dunn
Jennie Conroy
Kat Brunet
Paul French
Richard P Bentall
Rory Byrne
Sophie Parker
Tony Reilly
P2860
P356
10.1136/BMJ.E2233
10.1136/BMJ.E360
P407
P50
P577
2012-04-05T00:00:00Z